Severe acute respiratory syndrome coronavirus (SARS-CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E), Human coronavirus OC43 (HCoV-OC43), Human coronavirus NL63 (HCoV-NL63), Human coronavirus HKU1 (HCoV-HKU1)
ELISA, Neutralization
Human
Monoclonal
IgG1, lambda
76E1
Human astrovirus-1 (HAstV-1)
ELISA, Neutralization
Human
Monoclonal
IgG
3H4
Human astrovirus-1 (HAstV-1)
ELISA, Neutralization
Human
Monoclonal
IgG
3B4
Human astrovirus-2 (HAstV-2)
ELISA, Neutralization
Human
Monoclonal
IgG
4B6
Influenza A virus
ELISA, BLI, in vivo protection, in vitro neutralization
Human
Monoclonal
IgG1, kappa
H7-235
Influenza A virus (H7N1), Influenza A virus (H7N3)
ELISA, IF, BLI, in vivo protection, in vitro neutralization
Human
Monoclonal
IgG1, kappa
07-4B03
Influenza A virus
ELISA, in vivo protection, in vitro neutralization
Human
Monoclonal
P52E03
Influenza A virus (H7N3), Influenza A virus (H7N9)
ELISA, IF, in vivo protection, in vitro neutralization
Human
Monoclonal
IgG1, kappa
H7.167
Sin Nombre virus (SNV)
ELISA, Neutralization, BLI
Human
Monoclonal
IgG1, lambda
SNV-42
Theileria parva
ELISA, BLI, Neutralization
Human
Monoclonal
IgG1
SAA2263